Expression of E-cadherin and its relation to the p53 protein status in human breast carcinomas - PubMed (original) (raw)
. 1997 Nov;431(5):317-21.
doi: 10.1007/s004280050105.
Affiliations
- PMID: 9463572
- DOI: 10.1007/s004280050105
Expression of E-cadherin and its relation to the p53 protein status in human breast carcinomas
I K Bukholm et al. Virchows Arch. 1997 Nov.
Abstract
In breast carcinomas the TP53 gene is altered in 10-30% of cases. Alteration of the gene may lead to a general genomic instability, detected as deletions and/or amplifications at the gene level, and as altered expression at the mRNA and protein level. We have demonstrated a strong association between down-regulation of E-cadherin protein expression and alterations of the p53 protein, detected as TP53 gene mutation and/or protein accumulation in tumour samples from 210 patients with breast carcinomas (P < 0.001). Investigation of allelic imbalance using microsatellite markers located near the E-cadherin locus was also performed. A higher frequency of loss of heterozygosity in the microsatellite marker closest to the E-cadherin locus was observed in samples with down-regulation of E-cadherin protein expression. A higher frequency of down-regulation of the E-cadherin protein expression was found in invasive lobular carcinomas than in invasive ductal carcinomas, although this difference was of borderline significant (P = 0.084). Cases in the present series were also immunostained for cerB-2 protein overexpression. A significant association between p53 protein accumulation and cerbB-2 protein overexpression was seen (P = 0.036). The results of the present study indicate that p53 protein may play a role in regulation of E-cadherin protein expression.
Similar articles
- Correlation of E-cadherin expression and routine immunohistochemistry panel in breast invasive ductal carcinoma.
Mohammadizadeh F, Ghasemibasir H, Rajabi P, Naimi A, Eftekhari A, Mesbah A. Mohammadizadeh F, et al. Cancer Biomark. 2009;5(1):1-8. doi: 10.3233/CBM-2009-0551. Cancer Biomark. 2009. PMID: 19242056 - Simultaneous loss of E-cadherin and catenins in invasive lobular breast cancer and lobular carcinoma in situ.
De Leeuw WJ, Berx G, Vos CB, Peterse JL, Van de Vijver MJ, Litvinov S, Van Roy F, Cornelisse CJ, Cleton-Jansen AM. De Leeuw WJ, et al. J Pathol. 1997 Dec;183(4):404-11. doi: 10.1002/(SICI)1096-9896(199712)183:4<404::AID-PATH1148>3.0.CO;2-9. J Pathol. 1997. PMID: 9496256 - Frequent E-cadherin gene inactivation by loss of heterozygosity in pleomorphic lobular carcinoma of the breast.
Palacios J, Sarrió D, García-Macias MC, Bryant B, Sobel ME, Merino MJ. Palacios J, et al. Mod Pathol. 2003 Jul;16(7):674-8. doi: 10.1097/01.MP.0000073974.42583.F7. Mod Pathol. 2003. PMID: 12861063 - Molecular and morphologic distinctions between infiltrating ductal and lobular carcinoma of the breast.
Yoder BJ, Wilkinson EJ, Massoll NA. Yoder BJ, et al. Breast J. 2007 Mar-Apr;13(2):172-9. doi: 10.1111/j.1524-4741.2007.00393.x. Breast J. 2007. PMID: 17319859 Review. - E-cadherin and loss of heterozygosity at chromosome 16 in breast carcinogenesis: different genetic pathways in ductal and lobular breast cancer?
Cleton-Jansen AM. Cleton-Jansen AM. Breast Cancer Res. 2002;4(1):5-8. doi: 10.1186/bcr416. Epub 2001 Nov 1. Breast Cancer Res. 2002. PMID: 11879552 Free PMC article. Review.
Cited by
- The R72P P53 mutation is associated with familial breast cancer in Jewish women.
Ohayon T, Gershoni-Baruch R, Papa MZ, Distelman Menachem T, Eisenberg Barzilai S, Friedman E. Ohayon T, et al. Br J Cancer. 2005 Mar 28;92(6):1144-8. doi: 10.1038/sj.bjc.6602451. Br J Cancer. 2005. PMID: 15756275 Free PMC article. - Role of E-cadherin gene in gall bladder cancer and its precursor lesions.
Priya TP, Kapoor VK, Krishnani N, Agrawal V, Agrawal S. Priya TP, et al. Virchows Arch. 2010 May;456(5):507-14. doi: 10.1007/s00428-010-0908-6. Epub 2010 Apr 8. Virchows Arch. 2010. PMID: 20376482 - Expression of E-Cadherin in breast carcinomas and its association with other biological markers - a prospective study.
Chintamani, Rekhi B, Bansal A, Bhatnagar D, Saxena S. Chintamani, et al. Indian J Surg Oncol. 2010 Jan;1(1):40-6. doi: 10.1007/s13193-010-0010-1. Epub 2010 Aug 7. Indian J Surg Oncol. 2010. PMID: 22930617 Free PMC article. - Excess beta-catenin promotes accumulation of transcriptionally active p53.
Damalas A, Ben-Ze'ev A, Simcha I, Shtutman M, Leal JF, Zhurinsky J, Geiger B, Oren M. Damalas A, et al. EMBO J. 1999 Jun 1;18(11):3054-63. doi: 10.1093/emboj/18.11.3054. EMBO J. 1999. PMID: 10357817 Free PMC article. - Real time PCR analyses of expression of E-cadherin, alpha-, beta- and gamma-catenin in human breast cancer for predicting clinical outcome.
Goyal A, Martin TA, Mansel RE, Jiang WG. Goyal A, et al. World J Surg Oncol. 2008 Jun 11;6:56. doi: 10.1186/1477-7819-6-56. World J Surg Oncol. 2008. PMID: 18547424 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous